| CARIS LIFE SCIENCES |
| USA |
| Gesundheit |
| US1421521071 / A41A14 |
| 49J (Frankfurt) / CAI (NASDAQ) |
| FRA:49J, ETR:49J, 49J:GR, NASDAQ:CAI |
| - |
| https://www.carislifescie.. |
|
Caris Life Sciences, Inc. is a precision medicine and diagnostic technology company focused on applying comprehensive molecular information and artificial intelligence to healthcare. Its current services include molecular profiling, genomic and diagn..
>Volltext.. |
| 5994.79 Mio. EUR |
| 5725.34 Mio. EUR |
| 950.93 Mio. EUR |
| 147.33 Mio. EUR |
| 87.15 Mio. EUR |
| 0.31 EUR |
| 420.08 Mio. EUR |
| 603.62 Mio. EUR |
| 69.11 Mio. EUR |
| 4.83 |
| 67.27% |
| - |
| - |
| - |
| - |
| - |
| CARIS LIFE |
| 17.11.26 |
|
||||
|